The Securities and Exchange Commission has not necessarily reviewed the information in this filing and has not determined if it is accurate and complete. | |||||||||||||||||
|
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 13F FORM 13F INFORMATION TABLE |
|
||||||||||||||||
| COLUMN 1 | COLUMN 2 | COLUMN 3 | COLUMN 4 | COLUMN 5 | COLUMN 6 | COLUMN 7 | COLUMN 8 | ||||
| VALUE | SHRS OR | SH/ | PUT/ | INVESTMENT | OTHER | VOTING AUTHORITY | |||||
| NAME OF ISSUER | TITLE OF CLASS | CUSIP | (x$1000) | PRN AMT | PRN | CALL | DISCRETION | MANAGER | SOLE | SHARED | NONE |
| Akari Therapeutics Plc | COM | 00972G108 | 2,296 | 158,352 | SH | SOLE | 158,352 | 0 | 0 | ||
| Alcobra Ltd | COM | M2239P109 | 3,043 | 484,500 | SH | SOLE | 484,500 | 0 | 0 | ||
| Anacor Pharmaceuticals Inc | COM | 032420101 | 15,901 | 140,756 | SH | SOLE | 140,756 | 0 | 0 | ||
| ARCA biopharma Inc | COM | 00211Y100 | 2,150 | 462,399 | SH | SOLE | 462,399 | 0 | 0 | ||
| Ascendis Pharma A/S | COM | 04351P101 | 1,649 | 90,000 | SH | SOLE | 90,000 | 0 | 0 | ||
| Avalanche Biotechnologies Inc | COM | 05337G107 | 10,498 | 1,102,735 | SH | SOLE | 1,102,735 | 0 | 0 | ||
| Coherus Biosciences Inc | COM | 19249H103 | 14,029 | 611,010 | SH | SOLE | 611,010 | 0 | 0 | ||
| Cynapsus Therapeutics Inc | COM | 23257Y701 | 1,703 | 110,226 | SH | SOLE | 110,226 | 0 | 0 | ||
| CytomX Therapeutics Inc | COM | 23284F105 | 1,565 | 75,000 | SH | SOLE | 75,000 | 0 | 0 | ||
| DBV Technologies | COM | F2927N109 | 32,506 | 463,643 | SH | SOLE | 463,643 | 0 | 0 | ||
| Edge Therapeutics Inc | COM | 279870109 | 1,688 | 135,000 | SH | SOLE | 135,000 | 0 | 0 | ||
| Flamel Technologies S.A. | COM | 338488109 | 6,105 | 500,000 | SH | SOLE | 500,000 | 0 | 0 | ||
| Global Blood Therapeutics | COM | 37890U108 | 1,962 | 60,691 | SH | SOLE | 60,691 | 0 | 0 | ||
| GW Pharmaceuticals | COM | 36197T103 | 21,655 | 311,853 | SH | SOLE | 311,853 | 0 | 0 | ||
| Heron Therapeutics Inc | COM | 427746102 | 29,256 | 1,095,734 | SH | SOLE | 1,095,734 | 0 | 0 | ||
| Lipocine Inc | COM | 53630X104 | 10,989 | 849,921 | SH | SOLE | 849,921 | 0 | 0 | ||
| Ocera Therapeutics | COM | 67552A108 | 2,196 | 703,730 | SH | SOLE | 703,730 | 0 | 0 | ||
| ProNAI Therapeutics Inc | COM | 74346L101 | 1,128 | 75,000 | SH | SOLE | 75,000 | 0 | 0 | ||
| REGENXBIO Inc | COM | 75901B107 | 872 | 52,500 | SH | SOLE | 52,500 | 0 | 0 | ||
| Stemline Therapeutics Inc | COM | 85858C107 | 855 | 135,420 | SH | SOLE | 135,420 | 0 | 0 | ||
| Zafgen Inc | COM | 98885E103 | 3,406 | 541,480 | SH | SOLE | 541,480 | 0 | 0 | ||